Key result
Dysferlin-deficient mice developed progressive muscular dystrophy with loss of sarcolemmal integrity despite an intact dystrophin glycoprotein complex and normal caveolin-3 levels.
Population
Two novel lines of dysferlin-deficient mice
Comparison
Dysferlin deficiency vs mdx and caveolin-3 deficient mice
Design
Preclinical
Authors
Loading...
Supports dysferlin-mediated sarcolemmal disruption as a distinct dystrophy pathway; hypothesis-generating for human mechanisms.
The study introduces two novel dysferlin-deficient mouse models that demonstrate muscle membrane disruption and myofiber degeneration are directly mediated by the loss of dysferlin, providing a new pathogenic mechanism in muscular dystrophies.
Mengfatt Ho (2004) studied Dysferlin deficiency (Limb girdle muscular dystrophy type 2B and Miyoshi myopathy). Dysferlin gene mutation (gene targeting and A/J strain retrotransposon insertion) vs. mdx and caveolin-3 deficient mice was evaluated on Muscle membrane disruption and myofiber degeneration. Dysferlin-deficient mice developed progressive muscular dystrophy with loss of sarcolemmal integrity despite an intact dystrophin glycoprotein complex and normal caveolin-3 levels.